Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “I.D.M. IMMUNO-DESIGNED”

14 pharma patents match "I.D.M. IMMUNO-DESIGNED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 14
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 14 pharmaceutical patents matching "I.D.M. IMMUNO-DESIGNED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

14 results for “I.D.M. IMMUNO-DESIGNED” · 30,257 patents in full index Clear search

  1. US 7252996

    Ancillary composition for the preparation of committed mature dentritic cells

    I.D.M. Immuno-Designed Molecules · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted

  2. US 6821516

    Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions

    I.D.M. Immuno-Designed Molecules · Granted Nov 23, 2004 · Expires Nov 18, 2024

    expired

  3. US 6737051

    Cell compositions containing macrophages, presenting anti-infectious and hematopoietic properties

    I.D.M. Immuno-Designed Molecules · Granted May 18, 2004 · Expires May 13, 2024

    expired

  4. US 6713056

    Combined preparation for the treatment of neoplasic diseases or of infectious diseases

    I.D.M. Immuno-Designed Molecules · Granted Mar 30, 2004 · Expires Mar 25, 2024

    expired

  5. US 6703016

    Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines

    I.D.M. Immuno-Designed Molecules · Granted Mar 9, 2004 · Expires Mar 4, 2024

    expired

  6. US 6616925

    Combined preparation for the treatment of neoplasic diseases or of infectious diseases

    I.D.M. Immuno-Designed Molecules · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  7. US 6596275

    Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions

    I.D.M. Immuno-Designed Molecules · Granted Jul 22, 2003 · Expires Jul 17, 2023

    expired

  8. US 6540994

    Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions

    I.D.M. Immuno-Designed Molecules · Granted Apr 1, 2003 · Expires Mar 27, 2023

    expired

  9. US 6399372

    Monocyte derived cells with immunostimulating properties, their preparation and uses

    I.D.M. IMMUNO-DESIGNED · Granted Jun 4, 2002 · Expires May 30, 2022

    expired

  10. US 6372499

    Polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes

    I.D.M. Immuno-Designed Molecules · Granted Apr 16, 2002 · Expires Apr 11, 2022

    expired

  11. US 6251858

    Derivatives of oligosides, their process of preparation and their applications

    I.D.M. Immuno-Designed Molecules · Granted Jun 26, 2001 · Expires Jun 21, 2021

    expired

  12. US 6221576

    Process for preparing macrophages, kits, and compositions for the use of this process

    I.D.M. Immuno-Designed Molecules · Granted Apr 24, 2001 · Expires Apr 19, 2021

    expired

  13. US 6140122

    Process for preparing macrophages, kits, and compositions for the use of this process

    I.D.M. Immuno-Designed Molecules · Granted Oct 31, 2000 · Expires Oct 26, 2020

    expired

  14. US 6051432

    Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions

    I.D.M. Immuno-Designed Molecules · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.